Andrew Hollman Meyer Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Andrew Hollman Meyer is Chief Business Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 82,139 shares of JANX, which is worth approximately $4.75 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 13,334 shares (Common Stock) at a price of $55.64 per share, resulting in proceeds of $741,903. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.1K
21.52% 3M change
n/a 12M change
Total Value Held $4.75 Million

Andrew Hollman Meyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Open market or private sale
$741,903 $55.64 p/Share
13,334 Reduced 13.97%
82,139 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
18,000 Added 15.86%
95,473 Common Stock
Dec 19 2024
BUY
Exercise of conversion of derivative security
$169,261 $17.13 p/Share
9,881 Added 11.31%
77,473 Common Stock
Sep 27 2024
SELL
Open market or private sale
$2,298,000 $45.96 p/Share
50,000 Reduced 42.52%
67,592 Common Stock
Sep 27 2024
BUY
Exercise of conversion of derivative security
$210,500 $4.21 p/Share
50,000 Added 29.83%
117,592 Common Stock
AHM

Andrew Hollman Meyer

Chief Business Officer
La Jolla, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX